Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
V., Fenselau, H., & Clemmensen, C
GLP-1 receptor activation enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through central nervous system effects
Oshis team understands what patients struggling with GI symptoms, including those taking GLP-1s, need: Integrated multidisciplinary care: Patients should receive coordinated care addressing each of their needs, with support from GI providers for diagnosis and medication, registered dietitians to pair GLP-1s with the right diet for sustainable improvement, behavioral health specialists to ease the anxiety around GLP-1 side effects for adherence, and care coordinators to work with their existing GLP-1 provider
PlexusDx tirzepatide is compounded by licensed 503A pharmacies and is not FDA-approved as a compounded formulation
US$ 21.42
US$ 27.83
US$ 22.18
US$ 20.39
